Literature DB >> 26950443

Sox9-induced chondrogenesis in mesenchymal stem cells was mediated by ERK5 signal pathway.

C Wang1, T Zhang1, W Liu1, H Meng1, Y Song2, W Wang3.   

Abstract

Sox9 is a member of the high-mobility-group (HMG) box protein superfamily, which is expressed predominantly among cells in mesenchymal condensations during the early development of embryonic skeletons. The extracellular-signal-regulated kinase 5 (ERK5) is one of the mitogen-activated protein kinase (MAPK) family members of protein kinases. Roles for ERK5 signaling in the regulation of chondrogenesis and adult chondrocyte homeostasis have yet to be demonstrated. In this study, we found that ERK5 could down-regulate Col2al and Sox9 expression, and this down-regulation was inhibited by MEK5β, one of ERK5 inhibitor. Furthermore, we characterized the ERK5 response with the chromatin binding profile of Sox9 in MSCs in a genome-wide manner through an analysis of ChIP-seq data. This study will help to understand the interaction between the ERK5 and Sox9, and facilitate to decipher the mechanism of chondrogenesis in mesenchymal stem cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26950443

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  2 in total

1.  Conditional ablation of MAPK7 expression in chondrocytes impairs endochondral bone formation in limbs and adaptation of chondrocytes to hypoxia.

Authors:  Xiaoming Yang; Dongmei Zhong; Wenjie Gao; Zhiheng Liao; Yuyu Chen; Shun Zhang; Hang Zhou; Peiqiang Su; Caixia Xu
Journal:  Cell Biosci       Date:  2020-09-10       Impact factor: 7.133

2.  Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells.

Authors:  Ignazia Tusa; Giulia Cheloni; Martina Poteti; Antonella Gozzini; Ngoc Ho DeSouza; Yi Shan; Xianming Deng; Nathanael S Gray; Shaoguang Li; Elisabetta Rovida; Persio Dello Sbarba
Journal:  Stem Cell Reports       Date:  2018-09-20       Impact factor: 7.765

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.